Details for 2009739263
Up to date per 04.04.2026
Actions
Details for 2009739263
Granted/Registered
European Patent
15.06.2011 A
29.06.2016 B1
29.08.2008
US
93234
G01N 33/68 20060101AFI20160201BHEP
Owner
Immedica Pharma ABNorrtullsgatan 15113 29 StockholmSE
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
SCHARSCHMIDT, BruceHyperion Therapeutics 601 Gateway Boulevard Suite 200 South San Francisco, CA 94080US
Information about Fees